PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non-small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors
CONCLUSION: PD-L1 expression on CTCs is a promising biomarker in patients with NSCLC treated with ICIs. Further validation as predictive biomarker is needed.PMID:33849808 | DOI:10.1016/j.cllc.2021.03.005
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Filippo G Dall'Olio Francesco Gelsomino Nicole Conci Laura Marcolin Andrea De Giglio Giada Grilli Francesca Sperandi Francesca Fontana Mario Terracciano Benedetta Fragomeno Nastassja Tober Giulia Manferrari Stefano Brocchi Rita Golfieri Michelangelo Fiore Source Type: research